Vilma P. Barcia MD, PhD, MSc· @DrVilmaPBarcia · X·· 2 days agoScore70
Body
🚨 #ESMO26 | DEWI phase II
Dostarlimab + watch & wait in localized dMMR/MSI-H GEJ cancer:🔹 67.4% (29/43) achieved cCR at 1 year with organ preservation.
🔹 No relapse or death in the W&W.
🌟 A potentially practice-changing, surgery-sparing strategy! #GIOnc @OncoAlert
264 views · 6 likes · 5 reposts · 0 replies
Conference abstracts
2877ROmatched by Rapid oral 1: Gastrointestinal tumour, upper digestive
Watch-and-wait (W&W) strategy for dostarlimab in localized deficient dMMR/MSI-H gastroesophageal adenocarcinoma (GEA): Results from the first interim analysis of the GERCOR-GONO DEWI phase II study
https://esmocongress.esmo.orgSource: Vilma P. Barcia MD, PhD, MSc · x.com